Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)
利伐沙班治疗癌症合并急性低风险肺栓塞患者 18 个月与 6 个月的疗效比较:一项开放标签、多中心、随机临床试验(ONCO PE 试验)
期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.124.072758
Yamashita, Yugo; Morimoto, Takeshi; Muraoka, Nao; Shioyama, Wataru; Chatani, Ryuki; Shibata, Tatsuhiro; Nishimoto, Yuji; Ogihara, Yoshito; Doi, Kosuke; Oi, Maki; Shiga, Taro; Sueta, Daisuke; Kim, Kitae; Tanabe, Yasuhiro; Koitabashi, Norimichi; Takada, Takuma; Ikeda, Satoshi; Nakagawa, Hitoshi; Tsukahara, Kengo; Shoji, Masaaki; Sakamoto, Jiro; Hisatake, Shinji; Ogino, Yutaka; Fujita, Masashi; Nakanishi, Naohiko; Dohke, Tomohiro; Hiramori, Seiichi; Nawada, Ryuzo; Kaneda, Kazuhisa; Ono, Koh; Kimura, Takeshi